Strata Critical Medical Statistics
Total Valuation
SRTA has a market cap or net worth of $500.99 million. The enterprise value is $446.67 million.
| Market Cap | 500.99M |
| Enterprise Value | 446.67M |
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTA has 86.53 million shares outstanding. The number of shares has increased by 7.82% in one year.
| Current Share Class | 86.53M |
| Shares Outstanding | 86.53M |
| Shares Change (YoY) | +7.82% |
| Shares Change (QoQ) | +6.46% |
| Owned by Insiders (%) | 13.62% |
| Owned by Institutions (%) | 57.09% |
| Float | 61.82M |
Valuation Ratios
The trailing PE ratio is 10.28.
| PE Ratio | 10.28 |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| Forward PS | 1.76 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.50 |
| EV / Sales | 1.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.93 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 5.47 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.35% and return on invested capital (ROIC) is -2.13%.
| Return on Equity (ROE) | -6.35% |
| Return on Assets (ROA) | -1.91% |
| Return on Invested Capital (ROIC) | -2.13% |
| Return on Capital Employed (ROCE) | -2.88% |
| Weighted Average Cost of Capital (WACC) | 16.20% |
| Revenue Per Employee | $699,012 |
| Profits Per Employee | $143,713 |
| Employee Count | 327 |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.28% in the last 52 weeks. The beta is 2.20, so SRTA's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | +61.28% |
| 50-Day Moving Average | 5.07 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 52.42 |
| Average Volume (20 Days) | 1,021,374 |
Short Selling Information
The latest short interest is 6.88 million, so 7.95% of the outstanding shares have been sold short.
| Short Interest | 6.88M |
| Short Previous Month | 6.40M |
| Short % of Shares Out | 7.95% |
| Short % of Float | 11.12% |
| Short Ratio (days to cover) | 7.59 |
Income Statement
In the last 12 months, SRTA had revenue of $228.58 million and earned $46.99 million in profits. Earnings per share was $0.56.
| Revenue | 228.58M |
| Gross Profit | 48.19M |
| Operating Income | -8.85M |
| Pretax Income | -16.05M |
| Net Income | 46.99M |
| EBITDA | -583,000 |
| EBIT | -8.85M |
| Earnings Per Share (EPS) | $0.56 |
Balance Sheet
The company has $58.79 million in cash and $4.47 million in debt, with a net cash position of $54.32 million or $0.63 per share.
| Cash & Cash Equivalents | 58.79M |
| Total Debt | 4.47M |
| Net Cash | 54.32M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 285.73M |
| Book Value Per Share | 3.30 |
| Working Capital | 103.20M |
Cash Flow
In the last 12 months, operating cash flow was -$44.78 million and capital expenditures -$12.16 million, giving a free cash flow of -$56.94 million.
| Operating Cash Flow | -44.78M |
| Capital Expenditures | -12.16M |
| Depreciation & Amortization | 8.26M |
| Net Borrowing | n/a |
| Free Cash Flow | -56.94M |
| FCF Per Share | -$0.66 |
Margins
Gross margin is 21.08%, with operating and profit margins of -3.87% and 20.56%.
| Gross Margin | 21.08% |
| Operating Margin | -3.87% |
| Pretax Margin | -7.02% |
| Profit Margin | 20.56% |
| EBITDA Margin | -0.26% |
| EBIT Margin | -3.87% |
| FCF Margin | n/a |
Dividends & Yields
SRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.82% |
| Shareholder Yield | -7.82% |
| Earnings Yield | 9.38% |
| FCF Yield | -11.37% |
Analyst Forecast
The average price target for SRTA is $9.13, which is 57.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.13 |
| Price Target Difference | 57.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.28% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTA has an Altman Z-Score of 5.59 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.59 |
| Piotroski F-Score | 3 |